A phase I dose-escalation study of lenalidomide in combination with gemcitabine in patients with advanced pancreatic cancer.

by Gustav J Ullenhag, Eva Rossmann, Maria Liljefors
Published 2015-01-01

Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer.

by Gustav J Ullenhag, Fariba Mozaffari, Mats Broberg, Håkan Mellstedt, Maria Liljefors
Published 2017-01-01

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib

by Marjut Niinivirta, Maria Georganaki, Gunilla Enblad, Cecilia Lindskog, Anna Dimberg, Gustav J. Ullenhag
Published 2020-04-01

Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitors

by Antonios Valachis, Camilla Rosén, Anthoula Koliadi, Evangelos Digkas, Alice Gustavsson, Andreas Nearchou, Gustav J Ullenhag
Published 2021-01-01

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma

by Bengt Tholander, Anthoula Koliadi, Johan Botling, Hanna Dahlstrand, Anne Von Heideman, Håkan Ahlström, Kjell Öberg, Gustav J. Ullenhag
Published 2020-10-01

TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Mel...

by Ylva Naeser, Hildur Helgadottir, Yvonne Brandberg, Johan Hansson, Roger Olofsson Bagge, Nils O. Elander, Christian Ingvar, Karolin Isaksson, Petra Flygare, Cecilia Nilsson, Frida Jakobsson, Olga del Val Munoz, Antonis Valachis, Malin Jansson, Charlotte Sparring, Lars Ohlsson, Ulf Dyrke, Dimitrios Papantoniou, Anders Sundin, Gustav J. Ullenhag
Published 2020-12-01